Department of Global Health, Boston University School of Public Health, 801 Massachusetts Avenue, Crosstown Center, 3rd Floor, 02118, Boston, MA, USA.
Carolina Population Center, University of North Carolina at Chapel Hill, 27516, Chapel Hill, NC, USA.
AIDS Behav. 2022 Dec;26(12):3834-3847. doi: 10.1007/s10461-022-03712-7. Epub 2022 Jun 15.
We assessed an intervention aimed at improving adherence to antiretroviral therapy (ART) among pregnant and postpartum women living with HIV (PPWLH). We randomized 133 pregnant women initiating ART in Uganda to receive text reminders generated by real time-enabled electronic monitors and data-informed counseling through 3 months postpartum (PPM3) or standard care. Intention-to-treat analyses found low adherence levels and no intervention impact. Proportions achieving ≥95% adherence in PPM3 were 16.4% vs. 9.1% (t = -1.14, p = 0.26) in intervention vs. comparison groups, respectively; 30.9% vs. 29.1% achieved ≥80% adherence. Additional analyses found significant adherence declines after delivery, and no effect on disease progression (CD4-cell count, viral load), though treatment interruptions were significantly fewer in intervention participants. Per-protocol analyses encompassing participants who used adherence monitors as designed experienced better outcomes, suggesting potential benefit for some PPWLH. The study was registered on ClinicalTrials.Gov (NCT02396394).
我们评估了一项旨在提高艾滋病毒感染孕妇和产后妇女(PPWLH)抗逆转录病毒治疗(ART)依从性的干预措施。我们在乌干达随机分配了 133 名开始接受 ART 的孕妇,这些孕妇在产后 3 个月(PPM3)期间接受实时电子监测器生成的短信提醒和数据驱动的咨询,或接受标准护理。意向治疗分析发现依从性水平较低,且干预无影响。在 PPM3 中达到 ≥95%依从性的比例,干预组为 16.4%,对照组为 9.1%(t = -1.14,p = 0.26);达到 ≥80%依从性的比例,干预组为 30.9%,对照组为 29.1%。进一步分析发现,产后依从性显著下降,且对疾病进展(CD4 细胞计数、病毒载量)无影响,但干预组的治疗中断明显减少。包含按设计使用依从性监测器的参与者的方案分析显示出更好的结果,提示一些 PPWLH 可能受益。该研究在 ClinicalTrials.Gov 上注册(NCT02396394)。